author-photo

Laurence Raizonville

Curie Institute

4

Papers

5

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC with residual disease—Preliminary results.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)